Tags : PD

Kyowa Kirin’s Istradefylline (KW-6002) Receives EMA’s MAA as an Adjunctive

Vartika Singh January 6, 2020

Shots: The approval is based on trials assessing KW-6002 vs PBO across EU, the US and Japan in patients with PD taking a stable dose of levodopa-based regimens with/out other PD medications The candidate will serve as an adjunctive treatment to the PD patients which is validated by the EMA and is now under review […]Read More

Pharma

Kyowa Annouces Ph IIa Results of KW-6356 for Parkinson’s Disorder

Vartika Singh August 21, 2018

Shots: The controlled, randomized Ph IIa trial in 168 patients with 58 HD KW6356 group,55 LD KW-6356 group, or a 55 placebo in ratio 1:1:1, with drug administration for 12 wks Results: Changes from baseline in MDS-UPDRS part III showed -4.76 in HD, -5.37 in LD, and -3.14 in PBO showing KW-6356 well tolerated and […]Read More

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Janssen Signs a Research Agreement with TenNor to Develop Treatments for Nontuberculous Mycobacteria Diseases

Boehringer Ingelheim Collaborates with Cure Genetics to Develop Next-Generation Liver-Targeted Gene Therapy

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Henlius’ HLX15 (biosimilar, daratumumab) Receives IND Approval for Multiple Myeloma in China

Celltrion Report Results of CT-P59 in P-II/III Study for COVID-19

The US Government to Purchase Additional Doses of Regeneron’s Casirivimab and Imdevimab to Combat COVID-19

Tessa’s CD30 CAR-T Therapy Receives EMA’s PRIME Designation for Relapsed or Refractory Classical Hodgkin Lymphoma

Genmab’s Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA’s Approval for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Nanobiotix Presents Results of NBTXR3 (PEP503) in P-Ib/II Study for Rectal Cancer at ASCO-GI 2021

Tags : PD

Kyowa Kirin’s Istradefylline (KW-6002) Receives EMA’s MAA as an Adjunctive

Kyowa Annouces Ph IIa Results of KW-6356 for Parkinson’s Disorder

Latest Posts

ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App

Philips to Acquire Capsule Technologies for ~$635M

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Tags : PD

Latest Posts

Categories

Related Topics